We also demonstrate the underlying regulatory mechanisms of Cur-mEVs in the treatment of AGA through upregulating Wnt/β-catenin signaling pathway, downregulating the expression of TGF-β1, as well as significantly reducing the levels of inflammation in the HF microenvironment. Here, TGFB1 is linked to hydrops fetalis.